Visual Inspection Is Key to Ensuring Patient Safety in US Pharmaceutical Compounded Products
A coauthored industry article examining visual inspection and product quality in the compounding setting.
Explore selected publications, professional coverage and original sources connected to healthcare compounding quality.
Find a publication, explore a topic, or follow a contribution back to its publisher. Each entry identifies Willis’s role.
4 results
A coauthored industry article examining visual inspection and product quality in the compounding setting.
Loyd V. Allen Jr. and Willis C. Triplett contribute a chapter to Drug Discovery and Development, third edition.
Professional reporting that features Willis’s perspective on compounding activity beyond the traditional pharmacy setting.
An AJHP letter by Willis C. Triplett, K. Gregory Humma, Mary Linda Stotter Cuddy and William H. Yates. PubMed identifies its publication type as a letter.
Links open at the publisher or indexing service. Publisher access and full-text availability vary. Selected publications and professional coverage are linked to their original sources.
Use these organizations’ own pages to explore their published materials and current communications.
USP’s official overview of its sterile-compounding chapter and related chapter resources.
Visit official sourceA starting point for FDA compounding information, policies, oversight and professional resources.
Visit official sourceOfficial communications about risks and quality concerns involving compounded drug products.
Visit official sourceProvider resources including checklists, educational materials and injection-safety tools.
Visit official sourceHave a quality question, a source worth exploring, or an idea for a future newsletter? Tell us what has your attention.